ActoBio

ActoBio

Precigen ActoBio is pioneering a new class of therapeutic agents created on the ActoBiotics™ platform.
  • Edit
DateInvestorsAmountRound

N/A

Spinout
*

$60.0m

Acquisition
Total Funding-

Recent News about ActoBio

Edit